New Search Search History

Holdings Information

    Clinical therapeutics primer : link to the evidence for the ambulatory care pharmacist / edited by Jennifer A. Reinhold, Grace Earl.

    • Title:Clinical therapeutics primer : link to the evidence for the ambulatory care pharmacist / edited by Jennifer A. Reinhold, Grace Earl.
    •    
    • Other Contributors/Collections:Reinhold, Jennifer A.
      Earl, Grace.
    • Published/Created:Burlington, MA : Jones & Bartlett Learning, ©2014.
    • Holdings

       
    • Library of Congress Subjects:Chemotherapy.
      Clinical pharmacology.
      Clinical medicine.
      Ambulatory medical care.
    • Medical Subjects: Pharmaceutical Services.
      Ambulatory Care.
      Chronic Disease--drug therapy.
      Evidence-Based Medicine.
      Pharmacists.
    • Description:xix, 444 pages : illustrations ; 26 cm
    • Notes:Includes bibliographical references and index.
    • ISBN:9781449633998 (pbk. : alk. paper)
      1449633994 (pbk. : alk. paper)
      9781449687977 (text with access code card)
      1449687970 (text with access code card)
    • Contents:Machine generated contents note: ch. 1 Approach to the Patient and Patient-Centered Care Process / Jennifer A. Reinhold
      Introduction
      Defining the Scope of Ambulatory Care Pharmacy Practice
      Individual Characteristics Needed for Ambulatory Practice
      Ambulatory Care Practice Models
      Ambulatory Care Practice Processes
      Patient-Centered Interviewing
      Navigating This Text
      Discussion Questions
      References
      ch. 2 Clinical Trial Evaluation and Biostatistics Primer / Gary Sloskey
      Introduction
      Study Design
      Components of a Primary Literature Publication
      Research Methods
      Evaluation of Research Results
      Confidence Intervals
      Statistical Tests and Application
      Discussion Questions
      References
      ch. 3 Evidence-Based Medicine and Its Application to Patient Care / Nicholas Leon
      Introduction
      Five-Step Approach to the Application of EBM
      Conclusion
      Discussion Questions
      References
      ch. 4 Special Populations and Considerations: Geriatric Patients / Laura A. Finn
      Introduction
      Changes of Aging
      Patient Evaluation
      Polypharmacy
      Identifying Medication-Related Problems
      Medication Appropriateness
      Unnecessary Drugs
      Medication Adherence and Self-Care
      Evidence-Based Medicine
      Discussion Questions
      References
      ch. 5 Special Populations and Considerations: Pediatric Patients / Laura L. Bio
      Approach to the Pediatric Patient
      Physiologic Changes in Pediatric Pharmacokinetics and Pharmacodynamics
      Pediatric Patient Evaluation
      Evidence-Based Medicine in the Pediatric Patient
      Special Considerations
      Self-Care
      Discussion Questions
      References
      ch. 6 Special Populations and Considerations: Pregnancy and Lactation / Lauren Czosnowski
      Introduction
      Physiology
      Patient Evaluation
      Evidence-Based Medicine
      Self-Care
      Discussion Questions
      References
      ch. 7 Special Populations and Considerations: Therapeutics of Renal Impairment / Valerie Shafir
      Introduction
      Pathophysiology
      Diagnostic Criteria/Patient Evaluation
      Evidence-Based Medicine
      Dyslipidemia in Chronic Kidney Disease
      Hypertension in Chronic Kidney Disease
      Discussion Questions
      References
      ch. 8 Special Populations and Considerations: Drug Dosing in Hepatic Impairment / Sanchita Sen
      Introduction
      Types of Liver Disease and Complications
      Pathophysiology
      Diagnostic Criteria and Patient Evaluation
      Evidence-Based Medicine
      Self-Care
      Discussion Questions
      References
      ch. 9 Hypertension / Eric Wright
      Introduction
      Definition and Pathophysiology
      Etiology and Epidemiology
      Diagnosis
      Complications
      Determination of Whether to Treat
      Staging of Hypertension
      Goal Blood Pressure
      Therapeutic Lifestyle
      Algorithmic Approach to Managing Hypertension
      Diuretics
      Combination Therapy
      Adherence
      Drugs Affecting the RAAS
      Calcium Channel Blockers
      Beta-Blockers
      Alpha-Blockers
      Centrally Acting Alpha-2 Agonists
      Direct Vasodilators
      Monitoring the Plan
      Special Populations
      Summary
      Discussion Questions
      References
      ch. 10 Diabetes / Tyan F. Thomas
      Introduction
      Pathophysiology
      Complications of Diabetes
      Diagnostic Criteria
      Patient Evaluation
      Evidence-Based Medicine
      Nondrug Therapies to Achieve Glycemic Goals
      Drug Therapies to Achieve Glycemic Goals
      Special Populations
      Self-Care
      Conclusion
      Discussion Questions
      References
      ch. 11 Dyslipidemia / Jennifer Malinowski
      Introduction
      Pathophysiology
      Lipids and Coronary Heart Disease
      Management
      Diagnostic Criteria and Patient Evaluation
      Presentation: Signs and Symptoms
      Lipid Panel Assessment
      Treatment Goals and Risk Stratification
      Primary Prevention
      Therapeutic Lifestyle Changes
      Secondary Prevention
      Medication Adherence and Persistence
      Adverse Events
      Other Populations
      Other Agents
      Conclusion
      Discussion Questions
      References
      ch. 12 Heart Failure / Grace Earl
      Introduction
      Pathophysiology
      Diagnostic Criteria and Patient Evaluation
      Evidence-Based Medicine
      Developing the Monitoring Plan
      Heart Failure with Normal Ejection Fraction
      Evidence Supporting Heart Failure Ambulatory Care Practice Models
      Discussion Questions
      References
      ch. 13 Anticoagulation / Sarah McBane
      Introduction
      Pathophysiology
      Patient Evaluation
      Evidence-Based Medicine: Pharmacotherapeutic Agents Utilized for Long-Term Anticoagulation
      Practice Guidelines
      Perioperative Management of Anticoagulation
      Special Considerations
      Warfarin Pharmacogenomics
      Self-Care
      Conclusion
      Discussion Questions
      References
      ch. 14 Generalized Anxiety Disorder / Christina Sebastiani
      Introduction
      Pathophysiology
      Diagnostic Criteria and Patient Evaluation
      Hamilton Anxiety Scale
      Evidence-Based Medicine
      Special Considerations
      Self-Care
      Discussion Questions
      References
      ch. 15 Major Depressive Disorder / Christina Sebastiani
      Introduction
      Pathophysiology
      Diagnostic Criteria and Patient Evaluation
      Evidence-Based Medicine
      Special Considerations
      Discussion Questions
      References
      ch. 16 Chronic Obstructive Pulmonary Disease and Asthma / Jonathan D. Ference
      Introduction
      Pulmonary Function Testing
      Chronic Obstructive Pulmonary Disease
      Asthma
      Role of Pharmacists in Respiratory Illness
      Discussion Questions
      References
      ch. 17 Bone Health / Lauren K. McCluggage
      Osteoporosis
      Osteoarthritis
      Rheumatoid Arthritis
      Discussion Questions
      References
      ch. 18 Human Immunodeficiency Virus / Kenneth George
      Introduction
      Pathophysiology
      Diagnostic Criteria and Patient Evaluation
      Evidence-Based Medicine
      Special Considerations
      Discussion Questions
      References
      ch. 19 Chronic Pain / Shannon Ryan Christiansen
      Introduction
      Pathophysiology
      Diagnostic Criteria and Patient Evaluation
      Evidence-Based Medicine
      Special Considerations
      Conclusion
      Discussion Questions
      Exam Questions
      References.
    Session Timeout
    New Session